Tag: bone marrow suppression
G1 Therapeutics gets Cosela FDA approval to reduce chemotherapy-induced bone marrow suppression
G1 Therapeutics has bagged approval for Cosela (trilaciclib) from the US Food and Drug Administration (FDA) for reducing bone marrow suppression caused by chemotherapy. Cosela ... Read More